120 related articles for article (PubMed ID: 38058174)
1. PER-CRISPR/Cas14a system-based electrochemical biosensor for the detection of ctDNA EGFR L858R.
Qi J; Qi Q; Zhou Z; Wu Y; Cai A; Wu J; Chen B; Wang Q; Chen L; Wang F
Anal Methods; 2023 Dec; 16(1):51-61. PubMed ID: 38058174
[TBL] [Abstract][Full Text] [Related]
2. A novel CRISPR/Cas14a-based electrochemical biosensor for ultrasensitive detection of Burkholderia pseudomallei with PtPd@PCN-224 nanoenzymes for signal amplification.
Li C; Liu C; Liu R; Wang Y; Li A; Tian S; Cheng W; Ding S; Li W; Zhao M; Xia Q
Biosens Bioelectron; 2023 Apr; 225():115098. PubMed ID: 36701949
[TBL] [Abstract][Full Text] [Related]
3. MscI restriction enzyme cooperating recombinase-aided isothermal amplification for the ultrasensitive and rapid detection of low-abundance EGFR mutations on microfluidic chip.
Xu S; Wang X; Wu C; Zhu X; Deng X; Wu Y; Liu M; Huang X; Wu L; Huang H
Biosens Bioelectron; 2024 Mar; 247():115925. PubMed ID: 38134625
[TBL] [Abstract][Full Text] [Related]
4. Improved EGFR mutation detection sensitivity after enrichment by Cas9/sgRNA digestion and PCR amplification.
Wang L; Jiang J; Li X; Li K; He R; Li J; Duan L; Luo W; Hu Z; Luo D
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1316-1324. PubMed ID: 33216845
[TBL] [Abstract][Full Text] [Related]
5. A tetrahedral DNA nanostructure-decorated electrochemical platform for simple and ultrasensitive EGFR genotyping of plasma ctDNA.
Wang X; Wu J; Mao W; He X; Ruan L; Zhu J; Shu P; Zhang Z; Jiang B; Zhang X
Analyst; 2020 Jul; 145(13):4671-4679. PubMed ID: 32458862
[TBL] [Abstract][Full Text] [Related]
6. EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.
Thress KS; Brant R; Carr TH; Dearden S; Jenkins S; Brown H; Hammett T; Cantarini M; Barrett JC
Lung Cancer; 2015 Dec; 90(3):509-15. PubMed ID: 26494259
[TBL] [Abstract][Full Text] [Related]
7. Detection of Epidermal Growth Factor Receptor Gene Status via a DNA Electrochemical Biosensor Based on Lambda Exonuclease-assisted Signal Amplification.
Weng X; Xu X; Huang P; Liu Z; Liu A; Chen W; Lin X
Anal Sci; 2020 Jun; 36(6):697-701. PubMed ID: 31866610
[TBL] [Abstract][Full Text] [Related]
8. Conductive metal-organic framework based label-free electrochemical detection of circulating tumor DNA.
Liu J; Yang S; Shen J; Fa H; Hou C; Yang M
Mikrochim Acta; 2022 Sep; 189(10):391. PubMed ID: 36138259
[TBL] [Abstract][Full Text] [Related]
9. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer.
Normanno N; Denis MG; Thress KS; Ratcliffe M; Reck M
Oncotarget; 2017 Feb; 8(7):12501-12516. PubMed ID: 27980215
[TBL] [Abstract][Full Text] [Related]
10. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
[TBL] [Abstract][Full Text] [Related]
11. [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].
Zhao J; Zhao J; Zhao X; Chen W; Zhong W; Zhang L; Li L; Wang M
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):25-32. PubMed ID: 23327870
[TBL] [Abstract][Full Text] [Related]
12. Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer.
Lee Y; Park S; Kim WS; Lee JC; Jang SJ; Choi J; Choi CM
Thorac Cancer; 2018 Sep; 9(9):1104-1110. PubMed ID: 29989342
[TBL] [Abstract][Full Text] [Related]
13. Detection of
Bai H; Xia J; Zhao X; Gong Z; Zhang D; Xiong L
J Clin Pathol; 2019 May; 72(5):379-385. PubMed ID: 30787028
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancer.
Janssen JM; Verheijen RB; van Duijl TT; Lin L; van den Heuvel MM; Beijnen JH; Steeghs N; van den Broek D; Huitema ADR; Dorlo TPC
Clin Transl Sci; 2022 Aug; 15(8):1916-1925. PubMed ID: 35775126
[TBL] [Abstract][Full Text] [Related]
15. A Novel CRISPR/Cas12a-Mediated Ratiometric Dual-Signal Electrochemical Biosensor for Ultrasensitive and Reliable Detection of Circulating Tumor Deoxyribonucleic Acid.
Dong J; Li X; Hou C; Hou J; Huo D
Anal Chem; 2024 May; 96(18):6930-6939. PubMed ID: 38652001
[TBL] [Abstract][Full Text] [Related]
16. Establishment of primary reference measurement procedures and reference materials for
Wang X; Zhang Y; Niu C; Wang S; Li L; Guo Y; Zhu L; Jin X; Gao H; Xu W; Zhu P; Lan Q; Du M; Cheng X; Gao Y; Dong L
Anal Methods; 2021 May; 13(18):2114-2123. PubMed ID: 33870958
[TBL] [Abstract][Full Text] [Related]
17. Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/R and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib.
Ou SI; Cui J; Schrock AB; Goldberg ME; Zhu VW; Albacker L; Stephens PJ; Miller VA; Ali SM
Lung Cancer; 2017 Jun; 108():228-231. PubMed ID: 28625641
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics.
Sheng Y; Zhang T; Zhang S; Johnston M; Zheng X; Shan Y; Liu T; Huang Z; Qian F; Xie Z; Ai Y; Zhong H; Kuang T; Dincer C; Urban GA; Hu J
Biosens Bioelectron; 2021 Apr; 178():113027. PubMed ID: 33529861
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-empowered electrochemical biosensor for target amplification-free and sensitive detection of miRNA.
Ma C; Zhou Q; Shi J; Gao H; Huang D; Xue H; Wang H; Zhang Z; Yang S; Zhang J; Zhang K
Talanta; 2024 Jan; 266(Pt 2):125125. PubMed ID: 37651913
[TBL] [Abstract][Full Text] [Related]
20. Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring.
Nesvet JC; Antilla KA; Pancirer DS; Lozano AX; Preiss JS; Ma W; Fu A; Park SM; Gambhir SS; Fan AC; Neal JW; Padda SK; Das M; Li T; Wakelee HA; Wang SX
Clin Chem; 2021 Mar; 67(3):534-542. PubMed ID: 33393992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
